Clinical Trials Sponsored by Action Medeor

Total 1441 results

Medeor Therapeutics, Inc.

Not yet recruiting

Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

Kidney Transplant Rejection
Medeor Therapeutics, Inc.

Recruiting

Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

Immune Tolerance

United States
Medeor Therapeutics, Inc.

Not yet recruiting

Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

Kidney Transplant Rejection
Action, France

Recruiting

Registry of Coronary Artery Ill Patients With Platelet Test Results (ONASSIST)

Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary Intervention

France
Action, France

Unknown

Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention (BIO TAVI)

Transcatheter Aortic Valve Replacement

France
Medeon Biodesign, Inc.

Completed

Clinical Study of the Medeon Biodesign XPro™

Percutaneous Closure of Arteriotomy in Common Femoral Artery

Taiwan, New Zealand, Australia
Abdul Latif Jameel Poverty Action Lab
Innovations for Poverty Action

Completed

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

HIV/AIDS | HSV-2 Infection
Action Pharma A/S

Completed

Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Valve Surgery | Cardiac Surgery | Coronary Artery Bypass Grafting | Aortic Root or Ascending Aortic Aneurysm Repair Surgery

Denmark
Pancreatic Cancer Action Network

Active, not recruiting

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer

United States
Action Pharma A/S

Completed

An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

Kidney Diseases | Coronary Artery Bypass | Valve Surgery | Cardiac Surgery | Aortic Aneurysm

Denmark
Action Pharma A/S

Terminated

Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Valve Surgery | Cardiac Surgery | Kidney Injury | Coronary Artery Bypass Grafting

United States
Aetion, Inc.

Completed

Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

Metastatic Lung Cancer | Non-small Cell Lung Cancer

United States
Aetion, Inc.

Completed

Dexamethasone and COVID-19 Inpatient Mortality

Coronavirus

United States
Aetion, Inc.

Active, not recruiting

Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments

COVID-19

United States
University of Minnesota
Innovations for Poverty Action; Peek Vision; Vision Action

Recruiting

Seeing to Learn in Sierra Leone (SLII)

Refractive Errors

Sierra Leone
MedSIR

Recruiting

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (EMPRESS)

Breast Cancer | Breast Cancer, Early-Onset

Spain, France
Meddoc

Completed

Bulbicam Validation on Glaucoma- and Cataract Patients

Cataract | Glaucoma Eye

Norway
Meddoc

Completed

Validation of Bulbicam for Parkinson- and Ataxia-patients

Parkinson Disease | Ataxia

Norway
MedSIR

Active, not recruiting

Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients (Phenomenal)

Breast Cancer Metastatic

Spain
MedSIR

Completed

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer (PARSIFAL)

Metastatic Breast Cancer

Spain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
MedSIR

Completed

Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib (TRASTYVERE)

Breast Neoplasm

Spain
MedSIR

Terminated

Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer (OPHELIA)

Advanced Breast Cancer

Spain
MedSIR

Terminated

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent (NOBROLA)

Breast Cancer

Spain
MedSIR

Completed

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC (BioPER)

Metastatic Breast Cancer

Spain, Italy
MedSIR

Completed

Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes (KELLY)

Breast Cancer

Spain
Medneon

Enrolling by invitation

The Informed Genetics Annotated Patient Registry (iGAP)

Predisposition, Genetic

United States
MedSIR

Terminated

Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients

Breast Cancer

Spain
MedSIR

Completed

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus (POEM)

Carcinoma, Endometrioid | mTOR Protein

Spain
MedSIR

Completed

Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment (MERIBEL)

Breast Neoplasm | Metastasis

Spain
Meddoc

Completed

Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose

GERD
MedSIR

Not yet recruiting

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (ANALLISA)

Ovarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
MedSIR

Recruiting

A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population (MiRaDoR)

Breast Cancer

Spain
MedSIR

Active, not recruiting

Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. (PHERGain)

Breast Cancer

Spain, Italy, France, United Kingdom, Germany, Portugal, Belgium
MedSIR

Withdrawn

POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer (POLTER)

Advanced Breast Cancer
MedSIR

Terminated

Checkpoint Blockade in COVID-19 Pandemic (COPERNICO)

COVID-19 | Pneumonia, Viral

Spain
Alliance for International Medical Action

Completed

COVID-19 STAndard of Care in Sub-Saharan Africa (COVISTA)

Covid19

Burkina Faso, Guinea
Alliance for International Medical Action

Completed

Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease (EVISTA)

Ebola Virus Disease

Congo, The Democratic Republic of the
Abdul Latif Jameel Poverty Action Lab
Innovations for Poverty Action; Development Media International

Unknown

Evaluation of a Mass Media Family Planning Campaign on the Uptake of Contraceptive Methods in Burkina Faso

Contraception | Family Characteristics | Family Size, Desired

Burkina Faso
AstraZeneca
Aetion, Inc.

Withdrawn

A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy (O-STEREO)

Pregnancy | Pregnant Women | Pregnancy Outcome
Aktion Bronchialkarzinom e.V.

Completed

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Non-Small-Cell Lung Carcinoma

Germany
MedSIR
Pfizer

Completed

PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (PALMIRA)

Breast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Spain, Germany, France, United Kingdom, Italy, Slovenia
MedSIR
Pfizer

Completed

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - (DxCARTES)

Breast Cancer

Spain, Portugal
Medela AG

Completed

Evaluation of the Reliability and Usability of the Reusable "BrownieForSymphony" Pump Set in Home Use (ESPII)

Lactation

Switzerland
Medela AG

Completed

Evaluation of Fluid-Filled Expression Core Technology Study - I (Effect-1)

Breast Pumping

Switzerland
Medela AG

Completed

Evaluation of the Reliability and Usability of the Reusable "BrownieForSymphony" Pump Set (ESP)

Lactation

Germany
Meditor SAS

Completed

Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock (ABDO-MIX)

Septic Shock | Peritonitis

France
MedSIR
Novartis

Recruiting

Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients (METALLICA)

Breast Cancer

Spain
Medela AG

Completed

Initiate Study Evaluating if Mothers Who Are Both Breastfeeding and Pumping in the First Days After Delivery Report Improved Comfort Levels With the New Symphony Program Card (Initiate)

Breast Pumping

Netherlands
MedSIR
GlaxoSmithKline

Completed

Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN) (LUZERN)

Breast Cancer | Breast Cancer Metastatic

Spain
Meddoc
Tine

Completed

Dose Estimation of Jarlsberg Cheese in Young, Active Norwegian Cross-country Skiers (XCS)

Healthy Nutrition

Norway

3

Subscribe